Independent equity research
Is Advantest Corporation (6857) a Buy, Hold or Sell?
Advantest Corporation — our independent, AI-built valuation and rating, in brief.
SELL (reduce into strength)
12-mo fair value
26,500.00
To fair value
−16%
By · report dated 2026-08-27 · fair value derived independently of the market price.
The thesis, in brief
At ¥35,700 Advantest discounts a third consecutive step-change in the SoC tester TAM on top of the $6.9bn-to-$11bn move already banked; if the CY2027 TAM the company guides in January lands at or below $12bn, mid-cycle EPS is nearer ¥800 than consensus's ¥1,155 for FY2027, and the shares de-rate
How we value it
We value Advantest Corporation using Mid-cycle P/E and EV/EBIT on normalised earnings, cross-checked by a 10-year FCFF DCF at 9.7% WACC. The 12-month fair value is set from that intrinsic estimate first, then compared to the market to read the upside or downside — never anchored to the current price.
What the full report covers
- Business & moat + industry cycle
- Earnings quality & normalized EPS
- Returns on capital (ROIC vs WACC)
- Balance-sheet safety
- Two independent valuations (DCF + multiples)
- Bear / base / bull fair values
- Earnings-call analysis
- Insider activity & positioning
- Technicals (RSI / ADX)
- A falsifiable thesis
Read the full Advantest Corporation report
The complete model, the scenarios, and every number behind the call — plus other names across the coverage. One subscription, cancel anytime.